U.S. CDC Confirms Their Approval for a COVID-19 Vaccine

The U.S. Food and Drug Administration issued the first emergency use authorization (EUA) on December 11, 2020, for a vaccine for the prevention of COVID-19 in individuals 16 years of age and older. Additionally, the U.S. CDC's Advisory Committee on Immunization Practices voted their approval during the afternoon of December 12, 2020.

“While not an FDA approval, today’s emergency use authorization of the Pfizer-BioNTech COVID-19 Vaccine holds the promise to alter the course of this pandemic in the United States,” commented Peter Marks, M.D., Ph.D., Director of the FDA’s Center for Biologics Evaluation and Research.

The EAU enables the experimental Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) to be distributed in the USA.